Quality of Life in Bladder Cancer Patients

Research output: Chapter in Book/Report/Conference proceedingChapterResearchpeer-review

Abstract

Because of the nature of the disease and its treatment characteristics, quality of life (QoL) issues are very important for patients with bladder cancer. However, very few high-quality studies have investigated this issue. In general, health-related quality of life (HRQOL) decreases following a bladder cancer diagnosis and continues for a prolonged period. HRQOL tends to decrease with increasing age and is associated with comorbid medical conditions. Among bladder cancer patients, QoL is not generally affected by treatment type. Overall QoL may also not differ according to diversion type, in radical cystectomy patients. However, one systematic review suggested that patients with orthotopic neobladders have superior emotional functioning and body image compared to those with ileal conduits. QoL studies involving non-muscle-invasive or metastatic bladder cancers are still very rare. By more completely understanding HRQOL issues, better treatment strategies may be chosen during informed decision-making. Thus, well-designed prospective studies evaluating QoL in patients with bladder cancer are required.

Original languageEnglish
Title of host publicationBladder Cancer
PublisherElsevier Inc.
Pages507-522
Number of pages16
ISBN (Electronic)9780128099407
ISBN (Print)9780128099391
DOIs
StatePublished - 14 Dec 2017

Fingerprint

Urinary Bladder Neoplasms
Quality of Life
Urinary Diversion
Body Image
Cystectomy
Decision Making
Therapeutics
Prospective Studies

Keywords

  • Bladder cancer
  • Quality of life
  • Quality-adjusted survival analysis
  • Urinary diversion
  • Utility

Cite this

Jeong, Chang Wook. / Quality of Life in Bladder Cancer Patients. Bladder Cancer. Elsevier Inc., 2017. pp. 507-522
@inbook{b88b13039bd742c8b53b7985b195e9bf,
title = "Quality of Life in Bladder Cancer Patients",
abstract = "Because of the nature of the disease and its treatment characteristics, quality of life (QoL) issues are very important for patients with bladder cancer. However, very few high-quality studies have investigated this issue. In general, health-related quality of life (HRQOL) decreases following a bladder cancer diagnosis and continues for a prolonged period. HRQOL tends to decrease with increasing age and is associated with comorbid medical conditions. Among bladder cancer patients, QoL is not generally affected by treatment type. Overall QoL may also not differ according to diversion type, in radical cystectomy patients. However, one systematic review suggested that patients with orthotopic neobladders have superior emotional functioning and body image compared to those with ileal conduits. QoL studies involving non-muscle-invasive or metastatic bladder cancers are still very rare. By more completely understanding HRQOL issues, better treatment strategies may be chosen during informed decision-making. Thus, well-designed prospective studies evaluating QoL in patients with bladder cancer are required.",
keywords = "Bladder cancer, Quality of life, Quality-adjusted survival analysis, Urinary diversion, Utility",
author = "Jeong, {Chang Wook}",
year = "2017",
month = "12",
day = "14",
doi = "10.1016/B978-0-12-809939-1.00028-X",
language = "English",
isbn = "9780128099391",
pages = "507--522",
booktitle = "Bladder Cancer",
publisher = "Elsevier Inc.",

}

Quality of Life in Bladder Cancer Patients. / Jeong, Chang Wook.

Bladder Cancer. Elsevier Inc., 2017. p. 507-522.

Research output: Chapter in Book/Report/Conference proceedingChapterResearchpeer-review

TY - CHAP

T1 - Quality of Life in Bladder Cancer Patients

AU - Jeong, Chang Wook

PY - 2017/12/14

Y1 - 2017/12/14

N2 - Because of the nature of the disease and its treatment characteristics, quality of life (QoL) issues are very important for patients with bladder cancer. However, very few high-quality studies have investigated this issue. In general, health-related quality of life (HRQOL) decreases following a bladder cancer diagnosis and continues for a prolonged period. HRQOL tends to decrease with increasing age and is associated with comorbid medical conditions. Among bladder cancer patients, QoL is not generally affected by treatment type. Overall QoL may also not differ according to diversion type, in radical cystectomy patients. However, one systematic review suggested that patients with orthotopic neobladders have superior emotional functioning and body image compared to those with ileal conduits. QoL studies involving non-muscle-invasive or metastatic bladder cancers are still very rare. By more completely understanding HRQOL issues, better treatment strategies may be chosen during informed decision-making. Thus, well-designed prospective studies evaluating QoL in patients with bladder cancer are required.

AB - Because of the nature of the disease and its treatment characteristics, quality of life (QoL) issues are very important for patients with bladder cancer. However, very few high-quality studies have investigated this issue. In general, health-related quality of life (HRQOL) decreases following a bladder cancer diagnosis and continues for a prolonged period. HRQOL tends to decrease with increasing age and is associated with comorbid medical conditions. Among bladder cancer patients, QoL is not generally affected by treatment type. Overall QoL may also not differ according to diversion type, in radical cystectomy patients. However, one systematic review suggested that patients with orthotopic neobladders have superior emotional functioning and body image compared to those with ileal conduits. QoL studies involving non-muscle-invasive or metastatic bladder cancers are still very rare. By more completely understanding HRQOL issues, better treatment strategies may be chosen during informed decision-making. Thus, well-designed prospective studies evaluating QoL in patients with bladder cancer are required.

KW - Bladder cancer

KW - Quality of life

KW - Quality-adjusted survival analysis

KW - Urinary diversion

KW - Utility

UR - http://www.scopus.com/inward/record.url?scp=85054753168&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-809939-1.00028-X

DO - 10.1016/B978-0-12-809939-1.00028-X

M3 - Chapter

SN - 9780128099391

SP - 507

EP - 522

BT - Bladder Cancer

PB - Elsevier Inc.

ER -